Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
- 1 April 1998
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 43 (4), 499-506
- https://doi.org/10.1002/ana.410430414
Abstract
The change of brain lesion load, measured on T2‐weighted magnetic resonance imaging (MRI) using computer‐assisted techniques, is a widely used secondary endpoint for phase III clinical trials in multiple sclerosis (MS). Collections, transfer, and analysis of the electronic data across multiple centers have all proved challenging and give rise to potential errors. However, many new acquisition schemes and postprocessing techniques have been developed; these may reduce scan times and result in better lesion conspicuity or lessen the human interaction needed for data analysis. This review considers many aspects of the use of MRI in clinical trials for MS and provides international consensus guidelines, derived from a task force of the European Magnetic Resonance Networks in Multiple Sclerosis (MAGNIMS) together with a group of North American experts. The main points considered are the organization of correctly powered trials and selection of participating sites; the appropriate choice of pulse sequences and image acquisition protocol given the current state of technology; quality assurance for data acquisition and analysis; accuracy and reproducibility of lesion load assessments; and the potential for the application of quantitative methods to other MRI‐derived measures of disease burden.Keywords
This publication has 58 references indexed in Scilit:
- Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment?Annals of Neurology, 2006
- A dual approach for minimizing false lesion classifications on magnetic resonance imagesMagnetic Resonance in Medicine, 1997
- Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- A high‐resolution three‐dimensional T1‐weighted gradient echo sequence improves the detection of disease activity in multiple sclerosisAnnals of Neurology, 1996
- Lesion volume measurement in multiple sclerosis: How important is accurate repositioning?Journal of Magnetic Resonance Imaging, 1996
- Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosisBrain, 1995
- Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosisAnnals of Neurology, 1995
- Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosisAnnals of Neurology, 1994
- Comparing the FAISE method with conventional dual‐echo sequencesJournal of Magnetic Resonance Imaging, 1991
- Rating neurologic impairment in multiple sclerosisNeurology, 1983